Early trial tests repurposed drug for autoimmune dryness disease
NCT ID NCT04496960
Summary
This study is testing the safety and side effects of a drug called tofacitinib in adults with Sjogren's syndrome, an autoimmune disease that causes severe dryness. For about six months, 23 participants will take either the drug or a placebo pill. Researchers will monitor for side effects and see if the drug shows any early signs of helping control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SJOGREN'S SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.